ASBP Financials
Aspire Biopharma Holdings Inc - Financial statements & key metrics
Stock Price
$5.41
Market Cap
$7.01M
EPS
$-7.09
Income Statement Highlights
Most Recent Quarter: 2025-12-31
Revenue
$6202.00
Gross Profit
$-116.00
Operating Income
$-19.35M
Net Income
$-24.48M
EPS (Diluted)
$-
Balance Sheet Highlights
Total Assets
$1.31M
Total Liabilities
$7.69M
Shareholders Equity
$-6.38M
Cash & Equivalents
$1.00M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-4.92M
CapEx
$0
Free Cash Flow
$-4.92M
Profitability Metrics
Gross Margin
16.3%
Operating Margin
-58.1%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is ASBP revenue?
ASBP's most recent quarterly revenue was $6202.00. Annual revenue can be calculated by summing the four most recent quarters.
Is ASBP profitable?
ASBP reported a loss of $24.48M in the most recent quarter.
What is ASBP market cap?
ASBP has a market capitalization of $7.01M, making it a small-cap stock.
Does ASBP have debt?
View ASBP's balance sheet for debt information.
What is ASBP cash flow?
ASBP's most recent quarterly free cash flow was $-4.92M.